Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Dianthus Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −6 vs. Q1 2023
- Shares held
- 29.0M
- −655.3K (−2.2%) vs. Q1 2023
- Total value
- $22.0M
- −$1.56M (−6.6%) vs. Q1 2023
- New holders
- 3
- 10 more added
- Sold out
- 9
- 12 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 16 | $0 | 0.00% | −3,225−99.5% | Reduced |
| Pension & Wealth Management Advisors, Inc. | 10 | $8 | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 50 | $38 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 52 | $39 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 375 | $285 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 703 | $533 | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 742 | $562 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 779 | $591 | 0.00% | +13+1.7% | Added |
| BNP Paribas Arbitrage, SA | 4,474 | $3.39K | 0.00% | −406−8.3% | Reduced |
| Royal Bank of Canada | 5,843 | $4.00K | 0.00% | +471+8.8% | Added |
| Rathbone Brothers plc | 10,000 | $7.58K | 0.00% | 00.0% | Unchanged |
| Sound View Wealth Advisors Group, LLC | 10,500 | $7.96K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,177 | $8.47K | 0.00% | +8,380+299.6% | Added |
| Tower Research Capital LLC (TRC) | 12,190 | $9.24K | 0.00% | −999−7.6% | Reduced |
| Morgan Stanley | 16,866 | $12.8K | 0.00% | −500,173−96.7% | Reduced |
| XTX Topco Ltd | 26,932 | $20.4K | 0.00% | +26,932 | New |
| Charles Schwab Investment Management Inc | 27,369 | $20.7K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 27,917 | $21.2K | 0.00% | −305−1.1% | Reduced |
| Fiduciary Trust Co | 30,555 | $23.2K | 0.00% | 00.0% | Unchanged |
| Cheyne Capital Management (UK) LLP | 47,170 | $35.8K | 0.13% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 60,404 | $45.8K | 0.00% | −4,917−7.5% | Reduced |
| Northern Trust Corp | 71,463 | $54.2K | 0.00% | −25,872−26.6% | Reduced |
| Corsair Capital Management, L.P. | 100,000 | $75.8K | 0.03% | +67,154+204.5% | Added |
| Susquehanna International Group, LLP | 103,302 | $78.3K | 0.00% | −78,201−43.1% | Reduced |
| Two Sigma Investments, LP | 120,269 | $91.2K | 0.00% | +28,896+31.6% | Added |
| State Street Corp | 139,207 | $105.5K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 149,300 | $113.2K | 0.00% | −44,200−22.8% | Reduced |
| Harbor Capital Advisors, Inc. | 167,454 | $126.9K | 0.03% | +15,316+10.1% | Added |
| Two Sigma Advisers, LP | 177,400 | $134.5K | 0.00% | +23,346+15.2% | Added |
| Leonteq Securities AG | 200,000 | $151.6K | 0.02% | 00.0% | Unchanged |
| Bessemer Group Inc | 237,292 | $180.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 250,822 | $190.1K | 0.01% | 00.0% | Unchanged |
| Harvard Management Co Inc | 332,610 | $252.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 357,690 | $271.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 364,168 | $276.0K | 0.00% | −101,801−21.8% | Reduced |
| Verition Fund Management LLC | 378,272 | $286.7K | 0.00% | −1,820,193−82.8% | Reduced |
| Acadian Asset Management LLC | 457,690 | $346.0K | 0.00% | −156,523−25.5% | Reduced |
| Renaissance Technologies LLC | 481,700 | $365.0K | 0.00% | +88,300+22.4% | Added |
| Octagon Capital Advisors LP | 550,000 | $416.9K | 0.06% | +550,000 | New |
| Laurion Capital Management LP | 582,300 | $441.4K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,968,421 | $1.49M | 0.00% | 00.0% | Unchanged |
| Alphabet Inc. | 3,339,138 | $2.54M | 0.14% | 00.0% | Unchanged |
| Citadel Advisors LLC | 3,360,001 | $2.55M | 0.00% | +3,351,181+37,995.2% | Added |
| Atlas Venture Life Science Advisors, LLC | 3,791,698 | $2.87M | 0.36% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 5,000,000 | $3.79M | 0.46% | +5,000,000 | New |
| Tang Capital Management LLC | 6,060,000 | $4.59M | 0.68% | +10,000+0.2% | Added |
| Lion Point Capital, LP | 0 | $0 | 0.00% | −4,558,466−100.0% | Sold out |
| Western Standard LLC | 0 | $0 | 0.00% | −1,439,374−100.0% | Sold out |
| TCW Group Inc | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −157,670−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −152,700−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,724−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −254−100.0% | Sold out |